Pancreatic cancer/X
Feb 11, 2025, 11:18
Ignacio Garrido-Laguna: 2 posterchilds clinical trials make difference in pancreatic cancer
Ignacio Garrido-Laguna, Director of Phase 1 Program at Huntsman Cancer Institute, posted on X:
“Today clinic 2 posterchilds clinical trials make difference pancreatic cancer.
1 Kras G12D ongoing complete response multi RAS inhibitor trial for 2.5 years (Cycle 40!!).
2 patient with MTAP LOF >1 year on PRMT5 inhibitor. Focus on impactful clinical research.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 11, 2025, 11:11
Feb 11, 2025, 11:01
Feb 11, 2025, 10:48
Feb 11, 2025, 10:45
Feb 11, 2025, 10:42
Feb 11, 2025, 10:28
Feb 11, 2025, 10:28
Feb 11, 2025, 10:24